Contact | Print version | PDF version | Send article | RSS feed

Svein Lien appointed new CEO of Biotec Pharmacon ASA

12 Mar 2010 - Svein Lien has been appointed new CEO of Biotec Pharmacon, following Lars Viksmoen's decision to resign after 3 years as CEO. Svein Lien will assume the position with effect from 15 March, 2010.
 
Svein Lien (55) joins the company with a financial background and extensive experience from technology- and diagnostics businesses, most recently as CEO of Axis-Shield plc, the diagnostic company listed in London and Oslo.
 
"I am very much looking forward to this challenge" Svein Lien says. "I know the company very well from several years as a Board Member and have always been very confident with the technology platform and admired the highly skilled and talented organization. I also have a strong faith in the opportunities created by the close relation to the research community in Tromsø. We will need some more time to conclude on the roote cause behind the disappointing Phase III results and to clarify the strategic route forward. Following that we will inform the market, most likely via a capital market day in Q2."